Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy
E A Grimm, C M Smid, J J Lee, et al.
Anti-Cancer Drugs
|
November 26, 1999
Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma
A Y Bedikian, S S Legha, O Eton, et al.
Cancer Immunology, Immunotherapy : CII
|
November 1, 1993
Increase in the ability of human cancer cells to induce cytotoxic T lymphocytes by ultraviolet irradiation
Y Umezu, L B Augustus, D Seito, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1997
Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma
A Y Bedikian, S S Legha, O Eton, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
April 1, 1995
Interleukin-1 production in tumor cells of human melanoma surgical specimens
D S Tyler, G M Francis, M Frederick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight proteoglycan antigen
M W Pride, S Shuey, A Grillo-Lopez, et al.
Melanoma Research
|
May 3, 2001
Phase II evaluation of bryostatin-1 in metastatic melanoma
A Y Bedikian, C Plager, J R Stewart, et al.
Melanoma Research
|
December 22, 1999
Pilot study of intra-arterial cisplatin and intravenous vinblastine and dacarbazine in patients with melanoma in-transit metastases
O Eton, M East, S S Legha, et al.
Melanoma Research
|
October 1, 1994
Mechanism of the anti-tumour effect of biochemotherapy in melanoma: preliminary results
A C Buzaid, E A Grimm, F Ali-Osman, et al.
Cancer
|
March 30, 2000
A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy
O Eton, A C Buzaid, A Y Bedikian, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy
E A Grimm, C M Smid, J J Lee, et al.
Anti-Cancer Drugs
|
November 26, 1999
Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma
A Y Bedikian, S S Legha, O Eton, et al.
Cancer Immunology, Immunotherapy : CII
|
November 1, 1993
Increase in the ability of human cancer cells to induce cytotoxic T lymphocytes by ultraviolet irradiation
Y Umezu, L B Augustus, D Seito, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1997
Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma
A Y Bedikian, S S Legha, O Eton, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
April 1, 1995
Interleukin-1 production in tumor cells of human melanoma surgical specimens
D S Tyler, G M Francis, M Frederick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight proteoglycan antigen
M W Pride, S Shuey, A Grillo-Lopez, et al.
Melanoma Research
|
May 3, 2001
Phase II evaluation of bryostatin-1 in metastatic melanoma
A Y Bedikian, C Plager, J R Stewart, et al.
Melanoma Research
|
December 22, 1999
Pilot study of intra-arterial cisplatin and intravenous vinblastine and dacarbazine in patients with melanoma in-transit metastases
O Eton, M East, S S Legha, et al.
Melanoma Research
|
October 1, 1994
Mechanism of the anti-tumour effect of biochemotherapy in melanoma: preliminary results
A C Buzaid, E A Grimm, F Ali-Osman, et al.
Cancer
|
March 30, 2000
A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy
O Eton, A C Buzaid, A Y Bedikian, et al.
Page
of 4